Olink Holding AB - ADR OLK shares are trading lower by 6.2% at $18.10 Monday afternoon after the company reported worse-than-expected fourth-quarter EPS results.
Olink reported quarterly losses of 7 cents per share which missed the analyst consensus estimate of 3 cents. The company also reported $43.70 million in sales this quarter.
"Achieving or surpassing all of Olink's major operational milestones in 2021, our industry-leading execution is proof of the talent and drive of our entire organization," said Jon Heimer, CEO of Olink Proteomics.
"Olink entered the year in an exceptionally strong competitive position; with increased optimism about the proteomics market and high conviction in its leadership position, in 2022 and beyond."
See Also: Why Pfizer Shares Are Trading Lower Today
Olink has a 52-week high of $42.20 and a 52-week low of $10.64.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
